The TIDES USA: Oligonucleotide & Peptide Therapeutics program features concurrent tracks covering 6 scientific themes including in-depth development strategies, trends, and technologies across the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing.
May 7-10, 2023
San Diego, CA
Chad leads a team of scientists as Study Director and Principal Investigator, providing technical oversight to clients across all therapeutic areas. In addition, he heads research at Alturas with a focus on investigating and applying novel technologies to the bioanalytical challenges of our evolving industry.